Acadia Pharmaceuticals Inc. (ACAD)
Market Closed
16 Oct, 08:00 PM
$
19. 12
-0.59
-2.9934%
$
3.39B Market Cap
- P/E Ratio
- Div Yield
1.67M Volume
-0.34 Eps
$ 19.71
Previous Close 
Want to track ACAD and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Acadia Pharmaceuticals Inc. (ACAD) Statistics
Valuation metrics
Market Cap 3.39B
Enterprise value 3.08B
Trailing P/E (ttm) 8.79
Forward P/E 23.63
PEG ratio 0.13
Price/Sales (ttm) 2.97
Price/Book (mrq) 2.6
Enterprise Value/Revenue 2.7
Enterprise Value/EBITDA 26.49
Overview
Shares outstanding 171.09M
Float 127.25M
Shares short 11.16M
% Held by insiders 0%
% Held by institutions 0.99%
Average volume (10 days) 2.1M
Average volume (90 days) 1.52M
Price summary
52-Week low 18.39
52-Week high 30.96
Beta 0.86
50-Day moving average 24.7
200-Day moving average 22.73
Financials
Fiscal year
Fiscal year ends 31 Dec 2025
Most recent quarter (mrq) 31 Mar 2026
Profitability
Profit margin 0.33%
Operating margin 0.08%
Operational effectiveness
Return on assets 0.22%
Return on equity 0.32%
Income Statement
Revenue (ttm) 1.1B
Revenue per share (ttm) 6.64
Quarterly revenue growth (yoy) 0.1%
Gross profit (ttm) 674.45M
EBITDA 116.57M
Net income to common (ttm) 375.65M
Diluted EPS (ttm) 2.22
Quarterly earnings growth (yoy) -0.81%
Balance Sheet
Total cash (mrq) 851.46M
Total cash per share (mrq) 5.57
Total debt (mrq) 50.79M
Total Debt/Equity (mrq) 0.06
Current ratio (mrq) 3.39%
Book value per share (mrq) 7.61
Cash Flow
Cash flow statement 123.49M
Levered free cash flow (LFCF) 154.14M
2026 © Marketlog. All Rights Reserved.
